The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
基本信息
- 批准号:10710813
- 负责人:
- 金额:$ 32.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:African Green MonkeyAgeAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer’s disease biomarkerAmyloid beta-42AnimalsBehaviorBehavioralBiological MarkersBloodBlood specimenBrainBrain regionCercopithecus tantalusCerebrumCharacteristicsComputer softwareDataDementiaDevelopmentDiseaseFoundationsFunctional disorderFutureGait speedGlucoseGoalsHealthHippocampusHomeHome environmentHumanImpairmentIndividualIntervention StudiesLAMC2 geneLightLiquid substanceLongitudinal StudiesMagnetic Resonance ImagingMeasuresMemoryMetabolicMethodologyModelingMonitorMotor ActivityMovementNerve DegenerationPatternPhasePlasmaPositioning AttributePositron-Emission TomographyPreventive measurePrimatesResearchResourcesSedation procedureShort-Term MemorySignal TransductionSpace PerceptionSpeedStructureSystemTREM2 geneTechnologyTimeage effectage relatedagedaging brainamnestic mild cognitive impairmentamyloid pathologybehavior measurementbiomedical resourcecognitive testingfluorodeoxyglucose positron emission tomographyforestfrontal lobeglucose metabolismmental statemetabolic rateneurofilamentneuropathologysensorsocial grouptau-1vervet
项目摘要
PROJECT SUMMARY
Vervet monkeys (Chlorocebus aethiops sabaeus) develop age-related amyloid pathology that resembles very
early stages of Alzheimer's disease in humans. Hippocampal hypometabolism and volume reduction occur in
amnestic mild cognitive impairment in humans, a condition characterized by impaired everyday memory which
often precedes development of Alzheimer's disease, but the effect of age on hippocampal function in vervets is
not known. Determining how age and Alzheimer's-related biomarkers are associated with hippocampal
structure and function in vervets would dramatically enhance the utility of this species as a model for age-
related cognitive impairments and early-stage Alzheimer's disease. As a first, exploratory step towards
characterizing hippocampal structure and function in aging vervets, the goal of this application is to develop a
continuous tracking system to monitor locomotor behavior in group-housed vervets in the Vervet Research
Colony at Wake Forest. This will allow us to monitor position within the home environment longitudinally for
long periods of time (weeks to months) and will allow us to determine whether locomotor behavior in aging
vervets displays patterns characteristic of dementia-associated "wandering" in humans. We will also measure
hippocampal volume with structural MRI and metabolic activity with FDG-PET imaging, and Alzheimer's-
related blood biomarkers. This will allow us to explore whether any features of movement around the home
enclosure discriminate between individuals based on hippocampal volume, glucose metabolic rate, or fluid
biomarkers of Alzheimer's disease. Because behavioral readouts of hippocampal function currently are mainly
obtained through prolonged cognitive testing, which is resource-intensive and impractical to apply across large
groups of primates, this proposal has the potential to uncover behavioral measures that can be continuously
acquired and analyzed in real time and over a period of months to years that signal hippocampal dysfunction
with aging and neuropathology in vervet monkeys. This will open new possibilities for using this model species
to study interventions that may offset the development of Alzheimer's pathology in humans during the earliest
phases of the disease.
项目摘要
Vervet猴子(Chlorocebus aethiops sabaeus)发展与年龄相关的淀粉样病理学,非常类似于
阿尔茨海默氏病在人类中的早期阶段。海马低代谢和减少体积发生在
人类中有敏感的轻度认知障碍,这种状况的特征是日常记忆受损
通常先于阿尔茨海默氏病的发展,但是年龄对黑vers次海马功能的影响是
不知道。确定年龄和阿尔茨海默氏症与海马的相关生物标志物如何相关
天文中的结构和功能将大大增强该物种的效用,作为年龄的模型
相关的认知障碍和早期阿尔茨海默氏病。作为探索性的第一步
表征海马结构和衰老的衰老的功能,该应用的目的是开发一个
连续跟踪系统,以监测Vervet研究中的小型天线中的运动行为
在维克森林的殖民地。这将使我们能够纵向监视家庭环境中的位置
长时间(每周至几个月),将使我们能够确定衰老的运动行为是否
Vervets显示了人类与痴呆相关的“徘徊”的特征。我们还将衡量
带有结构性MRI和代谢活性的海马体积,带有FDG-PET成像,而阿尔茨海默氏症
相关的血液生物标志物。这将使我们能够探索房屋周围运动的任何特征
基于海马体积,葡萄糖代谢率或液体的外壳区分个体
阿尔茨海默氏病的生物标志物。因为当前的海马功能的行为读数主要是
通过长时间的认知测试获得,这是资源密集型且不切实际的,可用于大型
灵长类动物的群体,该提案有可能发现可以不断的行为措施
实时获得和分析,并在数月到数年的时间内发出信号海马功能障碍
在Vervet猴子中衰老和神经病理学。这将为使用该模型物种开辟新的可能性
研究可能会在最早的人类病理学发展的干预措施中
疾病的阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Jorgensen其他文献
Matthew Jorgensen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Jorgensen', 18)}}的其他基金
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10285192 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
- 批准号:
10379068 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10612842 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
9471459 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10119382 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10806701 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10153904 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Cognitively engaging walking exercise and neuromodulation to enhance brain function in older adults
认知性步行锻炼和神经调节可增强老年人的大脑功能
- 批准号:
10635832 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别:
Dlgap2 as a Regulator of Alzheimer's Disease Related Cognitive Declines Via Synaptic Modifications
Dlgap2 通过突触修饰调节阿尔茨海默病相关的认知下降
- 批准号:
10606051 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别:
Improving Sleep and AD Biomarkers: A Pilot RCT of Citicoline
改善睡眠和 AD 生物标志物:胞二磷胆碱的试点随机对照试验
- 批准号:
10585583 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别:
KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
KLOTHO 和临床前 AD 中突触功能障碍的恢复力
- 批准号:
10587987 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别:
A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention To Increase Physical Activity in Adults with Intellectual Disability: Step it Up +
第一阶段试点测试多层次干预措施的可行性和有效性,以增加智力障碍成人的体力活动:加快步伐
- 批准号:
10585633 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别: